Skip to content
healthcare.dev

Bupropion Hydrochloride SR

NDC 50228-174, bupropion hydrochloride, tablet, film coated, extended release, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-174
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205794
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE100 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
50228-174-0150228017401100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-01)
50228-174-0550228017405500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-05)
50228-174-10502280174101000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-10)
50228-174-305022801743030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-30)
50228-174-605022801746060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/092da413-ec60-4577-ac57-51e3e42d55c9
  • NADAC price for package 50228017401

    GET /v1/drugs/nadac/50228017401
  • NADAC price for package 50228017405

    GET /v1/drugs/nadac/50228017405
  • NADAC price for package 50228017460

    GET /v1/drugs/nadac/50228017460

Use it

Look up 50228-174 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.